Skp2 and salivary cancer

Cancer Biology and Therapy

Volumn 8, Issue 2, 2009, Pages 153-158

  Ben Izhak, Ofer ^a   Akrish, Sharon ^a   Gan, Shlomit ^b   Nagler, Rafael M ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer; Malignancies; Prognosis; Salivary glands; Skp2

Indexed keywords

ANTINEOPLASTIC AGENT; HEPARANASE; PROTEIN P27; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 58749095671     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.2.7114     Document Type: Article

References (16)

1. Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ. Loss of the cell cycle inhibitors p21 (Cip1) and p27 (Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 2002; 21:8486-97.
2. Mazumder S, Dupree EL, Almasan A. A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr Cancer Drug Targets 2004; 4:65-75.
3. Spiro RH, Dubner S. Salivary gland tumors. Curr Opin Oncol 1990; 2:589-95.
4. Eneroth CM. Salivary gland tumors in the parotid gland, submandibular gland and the palate region. Cancer 1971; 27:1415-8.
5. Eveson JW, Cawson RA. Salivary gland tumors. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985; 146:51-8.
6. Nagler RM, Barak M, Ben-Aryeh H, Peled M, Filatov M, Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 1999; 35;1018-25.
7. Handra-Luca A, Ruhin B, Lesty C, Fouret P. p27, Skp2 and extra-cellular signal-related kinase signaling in human salivary gland mucoepidermoid carcinoma. Oral Oncol 2006; 42:1005-10.
8. Ben-Izhak O, Laster Z, Araidy S, Nagler RM. TUNEL - an efficient predicot of salivary malignancies. Br J Cancer 2007; 96:1101-6.
9. Ben Izhak O, Kaplan-Cohen V, Ilan N, Gan S, Vlodavsky I, Nagler R. Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival. Neoplasia 2006; 2:879-84.
10. Nagler R, Kerner H, Laufer D, Ben-Eliezer S, Minkov I, Ben-Ytzhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002; 186:137-50.
11. Ben-Izhak O, Kablan F, Laster Z, Nagler RM. Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert - first report. Oral Oncol 2005; 41:851-60.
12. Kip1 deregulation in colorectal cancer. Cancer 2006; 107:668-75.
13. Kudo Y, Kitajima S, Ogawa I, Miyauchi M, Takata T. Downregulation of Cdk inibitor p27 in oral squamous cell carcinoma. Oral Oncol 2005; 41:105-16.
14. Bloom J, Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 2003; 13:41-7.
15. Kip1. Biochem Biophys Res Commun 2001; 282:853-60.
16. Strianese D, Baldi G, Staibano S, Baldi A, De Rosa G, Tranfa F, Bonavolonta G. Expression of apoptosis-related markers in malignant epithelial tumors of the lacrimal gland and their relation to clinical outcome. Br J Ophthalmol 2007; 91:1239-43.